Dieter Pöhlau

2.4k total citations
53 papers, 1.3k citations indexed

About

Dieter Pöhlau is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Dieter Pöhlau has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pathology and Forensic Medicine, 13 papers in Neurology and 7 papers in Oncology. Recurrent topics in Dieter Pöhlau's work include Multiple Sclerosis Research Studies (42 papers), Peripheral Neuropathies and Disorders (7 papers) and Polyomavirus and related diseases (6 papers). Dieter Pöhlau is often cited by papers focused on Multiple Sclerosis Research Studies (42 papers), Peripheral Neuropathies and Disorders (7 papers) and Polyomavirus and related diseases (6 papers). Dieter Pöhlau collaborates with scholars based in Germany, Switzerland and United States. Dieter Pöhlau's co-authors include H. Przuntek, Joachim Kügler, Volker Hoffmann, M. Rieks, Sabine Twork, Jörg Klewer, Sebastian Schimrigk, Kerstin Hellwig, Carsten Lukas and Judith Haas and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of neurosurgery.

In The Last Decade

Dieter Pöhlau

48 papers receiving 1.2k citations

Peers

Countries citing papers authored by Dieter Pöhlau

Since Specialization

Citations

This map shows the geographic impact of Dieter Pöhlau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Pöhlau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Pöhlau more than expected).

Fields of papers citing papers by Dieter Pöhlau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Pöhlau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Pöhlau. The network helps show where Dieter Pöhlau may publish in the future.

Co-authorship network of co-authors of Dieter Pöhlau

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Pöhlau. A scholar is included among the top collaborators of Dieter Pöhlau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Pöhlau. Dieter Pöhlau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study 2023 ·Journal of Clinical Medicine ·Niklas Frahm, (unknown), David Ellenberger, Judith Haas, Micha Löbermann, (unknown), Dieter Pöhlau, (unknown), (unknown), Alexander Stahmann, (unknown), Friedemann Paul, Uwe K. Zettl	4
2	Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study 2023 ·Vaccines ·(unknown), Niklas Frahm, (unknown), David Ellenberger, Judith Haas, Micha Löbermann, Dieter Pöhlau, (unknown), (unknown), Alexander Stahmann, (unknown), Friedemann Paul, Uwe K. Zettl	2
3	SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study 2022 ·The Lancet Regional Health - Europe ·Niklas Frahm, (unknown), David Ellenberger, Judith Haas, Micha Loebermann, Tina Parciak, (unknown), Dieter Pöhlau, Jeff Rodgers, (unknown), (unknown), Alexander Stahmann, (unknown), Uwe K. Zettl, Rod Middleton	17
4	Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry 2021 ·Multiple Sclerosis Journal ·Stefan Blaschke, David Ellenberger, Peter Flachenecker, Kerstin Hellwig, Friedemann Paul, Dieter Pöhlau, Christoph Kleinschnitz, Paulus Rommer, Maria Adele Rueger, Uwe K. Zettl, Alexander Stahmann, Clemens Warnke	9
5	PND48 BURDEN OF MULTIPLE SCLEROSIS IN GERMANY — A MATCHED COHORT STUDY USING A LARGE CLAIMS DATABASE 2019 ·Value in Health ·Carl Heinz Wirsing von König, (unknown), Christoph Maas, (unknown), (unknown), (unknown), (unknown), Wolfgang Greiner, Stefan Braune, Dieter Pöhlau, Arnfin Bergmann, S. Braun	0
6	Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis: Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart® 2018 ·Advances in Therapy ·Peter Rieckmann, Matthias Schwab, Dieter Pöhlau, Iris‐Katharina Penner, (unknown), (unknown), Antonios Bayas	12
7	Study of the effectiveness of hippotherapy on the symptoms of multiple sclerosis – Outline of a randomised controlled multicentre study (MS-HIPPO) 2016 ·Contemporary Clinical Trials Communications ·(unknown), (unknown), Sabine Schickendańtz, Andreas Gerber‐Grote, Petra Schiller, Dieter Pöhlau	11
8	Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study 2015 ·PLoS ONE ·(unknown), Katrin Schüssel, (unknown), (unknown), Martin Schulz, Robert H. Friis, Dieter Pöhlau, Norbert Schmitz, Joachim Kügler	72
9	Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases 2015 ·Brain Behavior and Immunity ·Lawrence B. Afrin, Dieter Pöhlau, Martin Raithel, Britta Haenisch, Franz Ludwig Dumoulin, (unknown), Uwe Max Mauer, (unknown), Gerhard J. Molderings	38
10	Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS) 2010 ·Health and Quality of Life Outcomes ·Sabine Twork, (unknown), (unknown), Markus Wirtz, (unknown), Dieter Pöhlau, Jörg Klewer, Joachim Kügler	44
11	Kausale Therapie der multiplen Sklerose 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Dieter Pöhlau, M. Rieks, Thomas Postert, Volker Hoffmann, H. Przuntek	0
12	Immunomodulating drugs in multiple sclerosis: compliance, satisfaction and adverse effects evaluation in a German multiple sclerosis population 2007 ·Current Medical Research and Opinion ·Sabine Twork, Irmgard Nippert, P. Scherer, Jürgen Haas, Dieter Pöhlau, Joachim Kügler	40
13	Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients 2006 ·European Journal of Neurology ·Volker Hoffmann, W. Kuhn, Sebastian Schimrigk, (unknown), Kerstin Hellwig, Carsten Lukas, N. Brune, Dieter Pöhlau, H. Przuntek, Thomas Müller	25
14	Oral fumaric acid esters for the treatment of active multiple sclerosis: an open‐label, baseline‐controlled pilot study 2006 ·European Journal of Neurology ·Sebastian Schimrigk, N. Brune, Kerstin Hellwig, Carsten Lukas, Barbara Bellenberg, M. Rieks, Volker Hoffmann, Dieter Pöhlau, H. Przuntek	163
15	Botulinum toxin in patients with multiple sclerosis 2006 ·Journal of Neurology ·Christian Kabus, Martin Hecht, (unknown), Wolfgang H. Jost, Dieter Pöhlau, Sebastian von Stuckrad-Barre, Martin Winterholler	13
16	Effects of acute psychological stress on adhesion molecules, interleukins and sex hormones: implications for coronary heart disease 2003 ·Psychopharmacology ·Andreas Heinz, Derik Hermann, Michael N. Smolka, M. Rieks, Klaus-Jürgen Gräf, Dieter Pöhlau, W. Kuhn, Michael Bauer	81
17	Induction of Apoptosis of CD4+ T Cells by Immunomodulatory Therapy of Multiple Sclerosis with Glatiramer Acetate 2003 ·European Neurology ·M. Rieks, Volker Hoffmann, Orhan Aktaş, (unknown), (unknown), (unknown), Sebastian Schimrigk, H. Przuntek, Dieter Pöhlau	22
18	Efficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients 2003 ·Journal of the Neurological Sciences ·Volker Hoffmann, Sebastian Schimrigk, (unknown), Kerstin Hellwig, Carsten Lukas, (unknown), Dieter Pöhlau, H. Przuntek, Thomas Müller	26
19	A null mutation within the ciliary neurotrophic factor (CNTF)-gene: implications for susceptibility and disease severity in patients with multiple sclerosis 2002 ·Genes and Immunity ·Volker Hoffmann, Dieter Pöhlau, H. Przuntek, Jörg T. Epplen, Cornelia Hardt	17
20	The interferon gene cluster: a candidate region for MS predisposition? 1999 ·Genes and Immunity ·Bianca Miterski, (unknown), Jörg T. Epplen, Dieter Pöhlau, Cornelia Hardt, (unknown)	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact